Retour
60
Fourchette du Jour
24,97 €
25,76 €
Fourchette 52 Semaines
13,53 €
36,44 €
Volume
1 168 056
Moyenne 50J / 200J
28,35 €
/
23,72 €
Clôture Précédente
24,63 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -32,1 | 0,4 |
| P/B | 2,1 | 2,9 |
| ROE % | -8,1 | 3,8 |
| Net Margin % | -57,2 | 3,9 |
| Rev Growth 5Y % | 28,1 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
40,86 €
+62.3%
Low: 26,00 €
High: 74,00 €
BPA Prévisionnel
-4,36 €
CA Est.
45 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-1,27 €
-2,98 € – -0,27 €
|
710 M | 4 |
| FY2029 |
-3,23 €
-7,60 € – -0,68 €
|
410 M | 4 |
| FY2028 |
-4,65 €
-7,93 € – -2,94 €
|
140 M | 10 |
Points Clés
Revenue grew 28,13% annually over 5 years — strong growth
Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -360,05M
PEG of 0,42 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 91,88%
Croissance
Revenue Growth (5Y)
28,13%
Revenue (1Y)120,01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-8,11%
ROIC-18,78%
Net Margin-57,24%
Op. Margin-274,57%
Sécurité
Debt / Equity
0,24
Current Ratio13,09
Interest Coverage-8,77
Valorisation
P/E Ratio
-32,05
P/B Ratio2,07
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 120,01% | Revenue Growth (3Y) | -39,17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28,13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 139,74M | Net Income (TTM) | -79,99M |
| ROE | -8,11% | ROA | -5,40% |
| Gross Margin | 84,05% | Operating Margin | -274,57% |
| Net Margin | -57,24% | Free Cash Flow (TTM) | -360,05M |
| ROIC | -18,78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,24 | Current Ratio | 13,09 |
| Interest Coverage | -8,77 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -32,05 | P/B Ratio | 2,07 |
| P/S Ratio | 18,35 | PEG Ratio | 0,42 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,56B | Enterprise Value | 2,56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 139,74M | 63,52M | 377,71M | 60,92M | 51,84M |
| Net Income | -79,99M | -376,74M | -132,53M | -289,09M | -370,64M |
| EPS (Diluted) | -0,81 | -4,58 | -1,72 | -4,13 | -5,77 |
| Gross Profit | 117,45M | -304,04M | 377,71M | -250,67M | -180,29M |
| Operating Income | -383,69M | -415,57M | -176,49M | -338,48M | -392,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,48B | 1,10B | 1,46B | 1,34B | 1,47B |
| Total Liabilities | 242,82M | 370,28M | 478,39M | 608,24M | 647,72M |
| Shareholders' Equity | 1,24B | 733,55M | 981,33M | 733,47M | 826,74M |
| Total Debt | 293,88M | 161,43M | 172,69M | 179,01M | 147,64M |
| Cash & Equivalents | 294,94M | 281,97M | 435,90M | 232,77M | 559,99M |
| Current Assets | 1,27B | 878,15M | 1,21B | 1,09B | 1,27B |
| Current Liabilities | 96,94M | 182,07M | 205,57M | 223,60M | 213,44M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#34 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026